XML 81 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Nov. 23, 2022
Sep. 23, 2022
Aug. 09, 2022
Aug. 10, 2021
Aug. 05, 2021
Jun. 09, 2021
Jul. 21, 2021
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Jul. 21, 2022
Jul. 18, 2021
Jun. 30, 2021
Mar. 01, 2021
Oct. 13, 2020
Fair Value of Financial Instruments (Details) [Line Items]                              
Fair value of warrants         $ 2,500                    
Exercise price of the warrant (in Dollars per share)   $ 0.6427           $ 0.5 $ 10            
ATW NPA Warrants, description                 In conjunction with notes payable issued under the NPA (see Note 10, Notes Payable), on various dates in September 2020, January 2021 and March 2021, the Company issued warrants to a US-based investment firm to purchase an aggregate of 1,187,083 shares of Class A Common Stock with exercise price of $10.00 per share and expiration dates 7 years from the dates of issuance, which were adjusted for down-round provisions in the original warrant agreements. The fair value of the warrants was recorded in APIC because the warrants met the derivative accounting scope exception in ASC 815-40 for certain contracts involving an entity’s own stock. The Company estimated the fair value of warrants issued in January 2021 and March 2021 to be $2.0 million and the fair value of the warrants issued in September 2020 to be $0.5 million, which were included in APIC on the Consolidated Balance Sheets. The Company utilized the Black-Scholes valuation model to value the September 2020, January 2021, and March 2021 warrants. The Black-Scholes model requires the use of several assumptions including the warrant exercise price, the term of the warrants, the risk-free rate, the underlying stock price, and the volatility of the underlying stock price. On August 10, 2021, these warrants were replaced with the issuance of warrants with the rights to purchase 1,187,083 shares of Class A Common Stock at an exercise price of $10.00 per share and with the same expiration dates as the previous warrants. The number of shares and exercise prices were adjusted for down-round provisions in the original warrant agreements.             
Issurance of expiration date, term           7 years                  
Estimated the fair value             $ 2,200     $ 8,000          
Expiration date       Aug. 10, 2028                      
Commitment shares issued (in Shares) 789,016                            
Business combination, cash                             $ 10,000
Unregistered shares (in Shares)                             1,697,500
Transaction Services Agreement, Unregistered Shares To Be Issued In Conjunction With Merger, Shares (in Shares)                             690,000
Business combination                             $ 6,900
Price per share (in Dollars per share)                             $ 10
Registered shares (in Shares)                       2,387,500      
Fair value of liability                   12,600          
Unregistered shares (in Shares)                     2,387,500        
Private warrants (in Shares)                 80,000            
Total private warrants shares (in Shares)     563,420           563,420            
Fair value                 $ 600 0          
Non-cash conversion, description                 Additions during the year ended December 31, 2022 included non-cash conversion of $9.9 million Bridge warrants, which was charged to Change in fair value measurements in the Consolidated Statements of Operations for the year ended December 31, 2022, and cash contribution of $82.0 million to note payable, which was reduced by the original issuance discount of $8.2 million, resulting in a net cash contribution of $73.8 million.            
Additional Paid-in Capital [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Estimated the fair value                   5,100          
Commitment to Issue Class A Common Stock [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Liability                   32,900          
Change in fair value measurements                   20,300          
Ares Warrants [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Fair value of warrants                           $ 5,000  
Warrants (in Shares)         670,092                    
Exercise price of the warrant (in Dollars per share)         $ 10                    
Private Warrants [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Warrants (in Shares)                 594,551            
Class A Common Stock [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Warrants (in Shares)                         1,500,000    
Exercise price of the warrant (in Dollars per share)       $ 10 $ 10 $ 10     $ 10            
Purchase of warrant issued (in Shares)       1,187,083   1,500,000                  
Registered shares (in Shares)                 2,387,500            
Commitment to issue amount                     $ 32,900        
PSAC [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Estimated the fair value                 $ 100 $ 600          
Business Combination [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Liability                 $ 2,200            
Business Combination [Member] | Public Warrants [Member]                              
Fair Value of Financial Instruments (Details) [Line Items]                              
Warrants (in Shares)                 22,977,568